FDA Webview

Karyopharm sNDA Filed for Xpovio in Myelofibrosis

[ Price : $8.95]

Karyopharm Therapeutics files a supplemental NDA seeking accelerated approval for Xpovio (selinexor) in combination with ruxolitin...

FDA, SEC Sign MOU on Sharing Info on Medical-Product Companies

[ Price : $8.95]

FDA and the U.S. Securities and Exchange Commission sign an MOU to strengthen cooperation and share information involving compani...

First Oral Drug Indicated to Treat Dermatomyositis Approved

[ Price : $8.95]

The agency approves Priovant Therapeutics Lisraya (brepocitinib) tablets for treating dermatomyositis in adults.

Alert on Boston Scientifics Angiographic Catheters

[ Price : $8.95]

FDA issues an Early Alert after becoming aware that Boston Scientific sent a letter to customers recommending all Imager II Angiog...

FDA OKs Lilly's Mounjaro to Reduce CV Risk in Adults with Diabetes

[ Price : $8.95]

FDA approves Eli Lillys Mounjaro (tirzepatide) for lowering the risk of major adverse cardiovascular events.

FDA Approves Updated Covid-19 Vaccines for Upcoming Season

[ Price : $8.95]

FDA approves updated Covid-19 vaccines from Moderna, Pfizer-BioNTech and Novavax/Sanofi for the upcoming vaccination season.

FDA Hits Alar Pharmaceuticals Experimental Ketamine Promotion

[ Price : $8.95]

FDA issues Alar Pharmaceuticals an untitled letter over promotional materials for its investigational ketamine drug, ALA-3000, bec...

Study Finds Drug Approvals Increasingly Rely on Fewer Trials

[ Price : $8.95]

FDAs approval of new drugs is increasingly being supported by fewer clinical studies.

FDA Promotion Crackdown Enters New Phase: Attorneys

[ Price : $8.95]

Attorneys from Arnall Golden Gregory examine and offer advice on FDAs intensified scrutiny of drug advertising, advising companies...

Senate Report Raises Questions About Oversight of Mifepristone Providers

[ Price : $8.95]

A new report from Senate HELP chair Bill Cassidy (R-LA) targets FDA for allowing the abortion drug mifepristones Risk Evaluation a...

Pay Per View

Home / Pay Per View

Karyopharm sNDA Filed for Xpovio in Myelofibrosis

FDA, SEC Sign MOU on Sharing Info on Medical-Product Companies

First Oral Drug Indicated to Treat Dermatomyositis Approved

Alert on Boston Scientifics Angiographic Catheters

FDA OKs Lilly's Mounjaro to Reduce CV Risk in Adults with Diabetes

FDA Approves Updated Covid-19 Vaccines for Upcoming Season

FDA Hits Alar Pharmaceuticals Experimental Ketamine Promotion

Study Finds Drug Approvals Increasingly Rely on Fewer Trials

FDA Promotion Crackdown Enters New Phase: Attorneys

Senate Report Raises Questions About Oversight of Mifepristone Providers

Categories

Top News

Pay Per View

Home / Pay Per View

Karyopharm sNDA Filed for Xpovio in Myelofibrosis

FDA, SEC Sign MOU on Sharing Info on Medical-Product Companies

First Oral Drug Indicated to Treat Dermatomyositis Approved

Alert on Boston Scientifics Angiographic Catheters

FDA OKs Lilly's Mounjaro to Reduce CV Risk in Adults with Diabetes

FDA Approves Updated Covid-19 Vaccines for Upcoming Season

FDA Hits Alar Pharmaceuticals Experimental Ketamine Promotion

Study Finds Drug Approvals Increasingly Rely on Fewer Trials

FDA Promotion Crackdown Enters New Phase: Attorneys

Senate Report Raises Questions About Oversight of Mifepristone Providers

Categories

Top News

FDA Webview Free Daily e-Newsletter